In the news | 6th January 2014

Banking on biologics

American Laboratory

January 2014

Biologics means big bucks and big rewards. The pharma industry is keen to capitalize on this success as revenues are tipped to reach over $407 billion by 2018. By this time, more than 50% of the top 100 selling drugs will be biologics.

Read the full article here »

About IDBSContact us

More news

i3 annual event experience IDBS

i3 2023

IDBS is excited to announce that we will be running i3 in person in 2023. It will take place in the US in June. Don’t miss out on more exciting updates, coming soon, by registering your interest below!

Read more